MetaADEDB 2.0 @ LMMD
Ethylene Glycol
(LYCAIKOWRPUZTN-UHFFFAOYSA-N)
Structure
SMILES
OCCO
Molecular Formula:
C2H6O2
Molecular Weight:
62.068
Log P:
-1.0290
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
40.46
CAS Number(s):
107-21-1
Synonym(s)
1.
Ethylene Glycol
2.
1,2-Ethanediol
3.
2-Hydroxyethanol
4.
Monoethylene Glycol
5.
1,2 Ethanediol
6.
2 Hydroxyethanol
7.
Glycol, Ethylene
8.
Glycol, Monoethylene
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product use issueFAERS: 5710US FAERS
2Drug ineffectiveFAERS: 3182US FAERS
3Incorrect drug administration durationFAERS: 1848US FAERS
4Product use in unapproved indicationFAERS: 1375US FAERS
5Drug administered to patient of inappropriate ageFAERS: 1029US FAERS
6Circumstance or information capable of leading to medication errorFAERS: 989US FAERS
7Expired product administeredFAERS: 780US FAERS
8FlatulenceFAERS: 631US FAERS
9Inappropriate schedule of drug administrationFAERS: 629US FAERS
10OverdoseFAERS: 543OFFSIDES
US FAERS
11Drug prescribing errorFAERS: 491US FAERS
12Wrong technique in product usage processFAERS: 481US FAERS
13Incorrect dose administeredFAERS: 450US FAERS
14Product prescribing issueFAERS: 440US FAERS
15NauseaFAERS: 386
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
16Product taste abnormalFAERS: 333US FAERS
17Inappropriate PrescribingFAERS: 301US FAERS
18ConstipationFAERS: 29015977961CTD
US FAERS
19VomitingFAERS: 222
Canada Vigilance: 3
Canada Vigilance
US FAERS
20Drug effect delayedFAERS: 217US FAERS
21Product quality issueFAERS: 212US FAERS
22DysgeusiaFAERS: 202
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Abdominal PainFAERS: 197OFFSIDES
US FAERS
24Product label confusionFAERS: 192US FAERS
25Incorrect product administration durationFAERS: 187US FAERS
26Poor quality drug administeredFAERS: 187US FAERS
27Abdominal discomfortFAERS: 179OFFSIDES
US FAERS
28Expired drug administeredFAERS: 178US FAERS
29MalaiseFAERS: 173US FAERS
30Unevaluable eventFAERS: 150US FAERS
31DizzinessFAERS: 147
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
32Poor quality product administeredFAERS: 139US FAERS
33PainFAERS: 138339773CTD
OFFSIDES
US FAERS
34Extra dose administeredFAERS: 137US FAERS
35Feeling abnormalFAERS: 136US FAERS
36Drug administration errorFAERS: 123US FAERS
37Product solubility abnormalFAERS: 122US FAERS
38Prescribed overdoseFAERS: 119US FAERS
39Therapeutic response unexpectedFAERS: 117US FAERS
40AngerFAERS: 116US FAERS
41AnxietyFAERS: 116OFFSIDES
US FAERS
42PruritusFAERS: 113US FAERS
43No adverse eventFAERS: 99US FAERS
44Bowel movement irregularityFAERS: 97US FAERS
45HeadacheFAERS: 94US FAERS
46Drug ineffective for unapproved indicationFAERS: 85US FAERS
47UrticariaFAERS: 84US FAERS
48Wrong technique in drug usage processFAERS: 84US FAERS
49Drug effect incompleteFAERS: 79US FAERS
50Intercepted drug prescribing errorFAERS: 75US FAERS
51DiscomfortFAERS: 73US FAERS
52AstheniaFAERS: 71OFFSIDES
US FAERS
53DyspepsiaFAERS: 71US FAERS
54Product contamination physicalFAERS: 68US FAERS
55Weight decreasedFAERS: 68US FAERS
56Drug DependenceFAERS: 62US FAERS
57Product physical issueFAERS: 62US FAERS
58HypersensitivityFAERS: 60US FAERS
59Gastrointestinal motility disorderFAERS: 58US FAERS
60Intentional product use issueFAERS: 58US FAERS
61DehydrationFAERS: 55OFFSIDES
US FAERS
62Infrequent bowel movementsFAERS: 54US FAERS
63Blood glucose increasedFAERS: 52US FAERS
64Product use complaintFAERS: 51US FAERS
65FatigueFAERS: 50US FAERS
66Pharmaceutical product complaintFAERS: 48OFFSIDES
US FAERS
67Therapeutic product ineffectiveFAERS: 46US FAERS
68Burning sensationFAERS: 44OFFSIDES
US FAERS
69Drug effective for unapproved indicationFAERS: 43US FAERS
70Intercepted medication errorFAERS: 43US FAERS
71Drug label confusionFAERS: 42US FAERS
72Intentional product misuseFAERS: 42US FAERS
73Product label issueFAERS: 42US FAERS
74Prescribed underdoseFAERS: 39US FAERS
75Back PainFAERS: 38US FAERS
76Product physical consistency issueFAERS: 38US FAERS
77TremorFAERS: 38US FAERS
78Mood swingsFAERS: 37US FAERS
79Throat irritationFAERS: 37US FAERS
80Obsessive-Compulsive DisorderFAERS: 36US FAERS
81Adverse eventFAERS: 35US FAERS
82DysuriaFAERS: 35OFFSIDES
US FAERS
83Peripheral swellingFAERS: 35US FAERS
84Accidental exposure to product by childFAERS: 34US FAERS
85Incorrect drug administration rateFAERS: 33US FAERS
86Accidental overdoseFAERS: 32US FAERS
87Gastrointestinal PainFAERS: 32US FAERS
88RetchingFAERS: 32US FAERS
89Chest PainFAERS: 31OFFSIDES
US FAERS
90CryingFAERS: 31US FAERS
91Gastrointestinal sounds abnormalFAERS: 31US FAERS
92Medication ErrorFAERS: 30US FAERS
93ScreamingFAERS: 30US FAERS
94Anorectal discomfortFAERS: 26US FAERS
95Blood potassium increasedFAERS: 26OFFSIDES
US FAERS
96EructationFAERS: 26US FAERS
97PalpitationsFAERS: 26US FAERS
98ErythemaFAERS: 25US FAERS
99Inappropriate schedule of product administrationFAERS: 25US FAERS
100NervousnessFAERS: 25US FAERS
101ParanoiaFAERS: 25US FAERS
102SwellingFAERS: 25US FAERS
103nervous system disorderFAERS: 25US FAERS
104AlopeciaFAERS: 24OFFSIDES
US FAERS
105Product prescribing errorFAERS: 24US FAERS
106Incorrect product storageFAERS: 22US FAERS
107ChillsFAERS: 21US FAERS
108Irritable Bowel SyndromeFAERS: 20US FAERS
109Product packaging issueFAERS: 20US FAERS
110Product tamperingFAERS: 20US FAERS
111ArthralgiaFAERS: 19US FAERS
112Intestinal ObstructionFAERS: 19US FAERS
113Joint swellingFAERS: 19US FAERS
114Blood sodium decreasedFAERS: 18US FAERS
115Chest discomfortFAERS: 18US FAERS
116Personality ChangeFAERS: 18US FAERS
117Product administered to patient of inappropriate ageFAERS: 18US FAERS
118Product package associated injuryFAERS: 18US FAERS
119Rectal tenesmusFAERS: 18US FAERS
120Contraindicated product administeredFAERS: 17US FAERS
121Drug effect variableFAERS: 17US FAERS
122Intentional self-injuryFAERS: 17US FAERS
123Lip swellingFAERS: 17US FAERS
124Maternal exposure during pregnancyFAERS: 17US FAERS
125NocturiaFAERS: 17US FAERS
126ThirstFAERS: 17US FAERS
127ChokingFAERS: 16US FAERS
128ChromaturiaFAERS: 16US FAERS
129DyscheziaFAERS: 16US FAERS
130Acute kidney injuryFAERS: 156499799CTD
US FAERS
131Oropharyngeal painFAERS: 15OFFSIDES
US FAERS
132Product lot number issueFAERS: 15US FAERS
133Emotional disorderFAERS: 14US FAERS
134FlushingFAERS: 14US FAERS
135Middle insomniaFAERS: 14US FAERS
136TinnitusFAERS: 14US FAERS
137NasopharyngitisFAERS: 13US FAERS
138NephrolithiasisFAERS: 13US FAERS
139Product expiration date issueFAERS: 13US FAERS
140Urinary tract infectionFAERS: 13US FAERS
141VertigoFAERS: 13US FAERS
142LethargyFAERS: 12OFFSIDES
US FAERS
143Memory impairmentFAERS: 12US FAERS
144Product container seal issueFAERS: 12US FAERS
145SomnolenceFAERS: 12US FAERS
146DysphemiaFAERS: 11US FAERS
147MyalgiaFAERS: 11US FAERS
148Patient dissatisfaction with treatmentFAERS: 11US FAERS
149Product contaminationFAERS: 11US FAERS
150Product packaging quantity issueFAERS: 11US FAERS
151AgitationFAERS: 10US FAERS
152Depressed moodFAERS: 10US FAERS
153Dry skinFAERS: 10US FAERS
154DysphoniaFAERS: 10US FAERS
155HypotensionFAERS: 10US FAERS
156Intercepted drug administration errorFAERS: 10US FAERS
157Physical product label issueFAERS: 10US FAERS
158Poor quality sleepFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
159Rash erythematousFAERS: 10US FAERS
160Abdominal rigidityFAERS: 9US FAERS
161Bladder painFAERS: 9US FAERS
162Cerebrovascular accidentFAERS: 9US FAERS
163Excessive eye blinkingFAERS: 9US FAERS
164Exposure to unspecified agentFAERS: 9US FAERS
165IncontinenceFAERS: 9OFFSIDES
US FAERS
166Musculoskeletal PainFAERS: 9OFFSIDES
US FAERS
167DiverticulitisFAERS: 8OFFSIDES
US FAERS
168EpistaxisFAERS: 8US FAERS
169Feeling jitteryFAERS: 8US FAERS
170Incorrect route of drug administrationFAERS: 8US FAERS
171Liquid product physical issueFAERS: 8US FAERS
172RegurgitationFAERS: 8US FAERS
173Renal painFAERS: 8US FAERS
174StomatitisFAERS: 8US FAERS
175Urinary IncontinenceFAERS: 8US FAERS
176Accidental exposure to productFAERS: 7US FAERS
177Blood potassium decreasedFAERS: 7OFFSIDES
US FAERS
178Cold sweatFAERS: 7US FAERS
179Dental cariesFAERS: 7OFFSIDES
US FAERS
180Feeling ColdFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Head discomfortFAERS: 7US FAERS
182PallorFAERS: 7OFFSIDES
US FAERS
183Product container issueFAERS: 7US FAERS
184Rectal dischargeFAERS: 7US FAERS
185Tongue discomfortFAERS: 7US FAERS
186Toxicity to various agentsFAERS: 7US FAERS
187Urinary RetentionFAERS: 7US FAERS
188WheezingFAERS: 7US FAERS
189Circumstance or information capable of leading to device use errorFAERS: 6US FAERS
190Dark circles under eyesFAERS: 6US FAERS
191Drug dispensing errorFAERS: 6US FAERS
192Exposure during breast feedingFAERS: 6US FAERS
193Eye irritationFAERS: 6US FAERS
194Foreign body in respiratory tractFAERS: 6US FAERS
195InfluenzaFAERS: 6US FAERS
196Mental impairmentFAERS: 6US FAERS
197Oropharyngeal discomfortFAERS: 6US FAERS
198Product closure removal difficultFAERS: 6US FAERS
199Product depositFAERS: 6US FAERS
200Product preparation errorFAERS: 6US FAERS
201Product storage errorFAERS: 6US FAERS
202Therapeutic product effect incompleteFAERS: 6US FAERS
203Therapeutic response delayedFAERS: 6US FAERS
204AgeusiaFAERS: 5US FAERS
205AmnesiaFAERS: 5OFFSIDES
US FAERS
206Atrial FibrillationFAERS: 5US FAERS
207BlepharospasmFAERS: 5US FAERS
208Blood creatinine increasedFAERS: 5US FAERS
209Blood glucose decreasedFAERS: 5US FAERS
210Drug dose omissionFAERS: 5US FAERS
211DysarthriaFAERS: 5US FAERS
212Eye painFAERS: 5US FAERS
213Flank PainFAERS: 5US FAERS
214Head BangingFAERS: 5US FAERS
215HypophagiaFAERS: 5OFFSIDES
US FAERS
216Increased upper airway secretionFAERS: 5US FAERS
217Muscle strainFAERS: 5US FAERS
218Oral painFAERS: 5US FAERS
219PetechiaeFAERS: 5US FAERS
220Product used for unknown indicationFAERS: 5US FAERS
221RestlessnessFAERS: 5US FAERS
222SneezingFAERS: 5US FAERS
223SyncopeFAERS: 5US FAERS
224Therapeutic response unexpected with drug substitutionFAERS: 5OFFSIDES
US FAERS
225Visual ImpairmentFAERS: 5US FAERS
226Blood cholesterol increasedFAERS: 4US FAERS
227Blood iron decreasedFAERS: 4US FAERS
228Blood magnesium increasedFAERS: 4US FAERS
229Blood urine presentFAERS: 4OFFSIDES
US FAERS
230Choking sensationFAERS: 4OFFSIDES
US FAERS
231CholelithiasisFAERS: 4US FAERS
232CystitisFAERS: 4US FAERS
233Diabetes MellitusFAERS: 4US FAERS
234DysbacteriosisFAERS: 4US FAERS
235EczemaFAERS: 4US FAERS
236Educational problemFAERS: 4US FAERS
237Electrolyte imbalanceFAERS: 4US FAERS
238EpilepsyFAERS: 4US FAERS
239Failure to ThriveFAERS: 4US FAERS
240General physical health deteriorationFAERS: 4OFFSIDES
US FAERS
241HyperventilationFAERS: 4US FAERS
242Medication residue presentFAERS: 4US FAERS
243Myocardial InfarctionFAERS: 4US FAERS
244Night sweatsFAERS: 4US FAERS
245ObstructionFAERS: 4US FAERS
246Ocular discomfortFAERS: 4US FAERS
247PhotophobiaFAERS: 4US FAERS
248Rebound effectFAERS: 4US FAERS
249Secretion dischargeFAERS: 4US FAERS
250Skin irritationFAERS: 4US FAERS
251Skin reactionFAERS: 4US FAERS
252StressFAERS: 4US FAERS
253Suicide attemptFAERS: 4US FAERS
254Therapy changeFAERS: 4US FAERS
255Urine output increasedFAERS: 4US FAERS
256Activities of daily living impairedFAERS: 3US FAERS
257Anaphylactic shockFAERS: 3US FAERS
258AphasiaFAERS: 3US FAERS
259ArthritisFAERS: 3OFFSIDES
US FAERS
260Bladder discomfortFAERS: 3US FAERS
261Blood electrolytes decreasedFAERS: 3OFFSIDES
US FAERS
262Blood glucose abnormalFAERS: 3US FAERS
263Cardiac ArrestFAERS: 3US FAERS
264Clostridium difficile infectionFAERS: 3US FAERS
265ColectomyFAERS: 3US FAERS
266Conversion disorderFAERS: 3US FAERS
267DependenceFAERS: 3US FAERS
268Ear discomfortFAERS: 3US FAERS
269Epigastric discomfortFAERS: 3US FAERS
270Feeling of body temperature changeFAERS: 3OFFSIDES
US FAERS
271Foreign body aspirationFAERS: 3US FAERS
272GastroenteritisFAERS: 3US FAERS
273GlossitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
274Growth retardationFAERS: 3US FAERS
275HerniaFAERS: 3US FAERS
276HyperchlorhydriaFAERS: 3US FAERS
277InfectionFAERS: 3OFFSIDES
US FAERS
278InflammationFAERS: 3US FAERS
279Intestinal PerforationFAERS: 3US FAERS
280Large intestine perforationFAERS: 3US FAERS
281Limb injuryFAERS: 3US FAERS
282Mental status changesFAERS: 3OFFSIDES
US FAERS
283Mouth swellingFAERS: 3US FAERS
284Musculoskeletal discomfortFAERS: 3US FAERS
285Musculoskeletal stiffnessFAERS: 3US FAERS
286Obsessive thoughtsFAERS: 3US FAERS
287Oral pruritusFAERS: 3US FAERS
288PolyuriaFAERS: 3US FAERS
289Product closure issueFAERS: 3US FAERS
290Product complaintFAERS: 3US FAERS
291Product counterfeitFAERS: 3US FAERS
292Psychiatric symptomFAERS: 3US FAERS
293Respiratory arrestFAERS: 3US FAERS
294Respiratory tract congestionFAERS: 3US FAERS
295Separation Anxiety DisorderFAERS: 3US FAERS
296Serum serotonin decreasedFAERS: 3US FAERS
297Skin lesionFAERS: 3US FAERS
298Therapeutic response changedFAERS: 3US FAERS
299Therapy cessationFAERS: 3US FAERS
300ToothacheFAERS: 3US FAERS
301Vulvovaginal pruritusFAERS: 3US FAERS
302Wrong drug administeredFAERS: 3US FAERS
303AbasiaFAERS: 2US FAERS
304Abdominal tendernessFAERS: 2US FAERS
305Anal discomfortFAERS: 2US FAERS
306AngioedemaFAERS: 2OFFSIDES
US FAERS
307Anorectal swellingFAERS: 2US FAERS
308AnorexiaFAERS: 2US FAERS
309ApathyFAERS: 2US FAERS
310AphagiaFAERS: 2US FAERS
311Aphthous StomatitisFAERS: 2US FAERS
312Back disorderFAERS: 2US FAERS
313Bipolar DisorderFAERS: 2US FAERS
314Bladder spasmFAERS: 2US FAERS
315BlindnessFAERS: 2US FAERS
316Blood creatine increasedFAERS: 2OFFSIDES
US FAERS
317Blood pressure fluctuationFAERS: 2US FAERS
318Blood pressure inadequately controlledFAERS: 2US FAERS
319Blood urea increasedFAERS: 2US FAERS
320Bone painFAERS: 2US FAERS
321BronchitisFAERS: 2OFFSIDES
US FAERS
322Cardiac FlutterFAERS: 2US FAERS
323CataractFAERS: 2OFFSIDES
US FAERS
324CheilitisFAERS: 2US FAERS
325ColitisFAERS: 2US FAERS
326Contraindicated drug administeredFAERS: 2US FAERS
327CyanosisFAERS: 2US FAERS
328Death of relativeFAERS: 2US FAERS
329Decreased eye contactFAERS: 2US FAERS
330DeliriumFAERS: 2US FAERS
331DementiaFAERS: 2US FAERS
332Depression suicidalFAERS: 2US FAERS
333DermatitisFAERS: 2US FAERS
334Device ineffectiveFAERS: 2US FAERS
335Device use issueFAERS: 2US FAERS
336DiplopiaFAERS: 2US FAERS
337DisorientationFAERS: 2US FAERS
338Drug abuseFAERS: 2US FAERS
339Drug effect faster than expectedFAERS: 2US FAERS
340Drug exposure during pregnancyFAERS: 2US FAERS
341Drug exposure via breast milkFAERS: 2US FAERS
342Drug screen positiveFAERS: 2US FAERS
343Emotional distressFAERS: 2US FAERS
344EnuresisFAERS: 2US FAERS
345Foaming at mouthFAERS: 2US FAERS
346Gastric DilatationFAERS: 2US FAERS
347Gastric ulcerFAERS: 2US FAERS
348GastritisFAERS: 2US FAERS
349Gastrointestinal infectionFAERS: 2US FAERS
350HungerFAERS: 2US FAERS
351HyperacusisFAERS: 2US FAERS
352HypergeusiaFAERS: 2US FAERS
353IleusFAERS: 2US FAERS
354Inappropriate affectFAERS: 2US FAERS
355Intervertebral disc disorderFAERS: 2US FAERS
356LacerationFAERS: 2OFFSIDES
US FAERS
357Limb discomfortFAERS: 2US FAERS
358Lip exfoliationFAERS: 2US FAERS
359LymphadenopathyFAERS: 2US FAERS
360MalabsorptionFAERS: 2US FAERS
361MalnutritionFAERS: 2US FAERS
362Medication monitoring errorFAERS: 2US FAERS
363Micturition frequency decreasedFAERS: 2US FAERS
364Morbid thoughtsFAERS: 2US FAERS
365Multiple SclerosisFAERS: 2US FAERS
366Neck PainFAERS: 2US FAERS
367Neuropsychiatric syndromeFAERS: 2US FAERS
368OligodipsiaFAERS: 2US FAERS
369Oppositional Defiant DisorderFAERS: 2US FAERS
370Oral mucosal eruptionFAERS: 2US FAERS
371Packaging design issueFAERS: 2US FAERS
372Pelvic PainFAERS: 2US FAERS
373PresyncopeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
374Product difficult to swallowFAERS: 2US FAERS
375Product dose omissionFAERS: 2US FAERS
376Product formulation issueFAERS: 2US FAERS
377Product preparation issueFAERS: 2US FAERS
378Product substitution issueFAERS: 2US FAERS
379Respiratory distressFAERS: 2US FAERS
380Restless Legs SyndromeFAERS: 2US FAERS
381Saliva alteredFAERS: 2US FAERS
382SchizophreniaFAERS: 2US FAERS
383Seizure like phenomenaFAERS: 2US FAERS
384Sensory processing disorderFAERS: 2US FAERS
385Septic ShockFAERS: 2OFFSIDES
US FAERS
386SinusitisFAERS: 2OFFSIDES
US FAERS
387SluggishnessFAERS: 2US FAERS
388SomnambulismFAERS: 2US FAERS
389Therapeutic product effect delayedFAERS: 2US FAERS
390Therapeutic product ineffective for unapproved indicationFAERS: 2OFFSIDES
US FAERS
391Therapy non-responderFAERS: 2US FAERS
392Transcription medication errorFAERS: 2US FAERS
393UlcerFAERS: 2US FAERS
394Vulvovaginal drynessFAERS: 2US FAERS
395colonoscopyFAERS: 2US FAERS
396furuncleFAERS: 2US FAERS
397treatment failureFAERS: 2US FAERS
398Abdominal adhesionsFAERS: 1US FAERS
399Abnormal sleep-related eventFAERS: 1US FAERS
400Absent bowel movementFAERS: 1US FAERS
401Accidental underdoseFAERS: 1US FAERS
402AcneFAERS: 1US FAERS
403Adjustment disorder with depressed moodFAERS: 1US FAERS
404Adnexa uteri painFAERS: 1US FAERS
405Alanine Aminotransferase IncreasedFAERS: 1OFFSIDES
US FAERS
406AlveolitisFAERS: 1OFFSIDES
US FAERS
407Ammonia increasedFAERS: 1US FAERS
408Amyotrophic Lateral SclerosisFAERS: 1US FAERS
409Anal spasmFAERS: 1US FAERS
410Angina PectorisFAERS: 1US FAERS
411Ankle FractureFAERS: 1US FAERS
412Anorectal operationFAERS: 1US FAERS
413AnosmiaFAERS: 1OFFSIDES
US FAERS
414Anticoagulation drug level decreasedFAERS: 1US FAERS
415AnuriaFAERS: 1US FAERS
416Aortic AneurysmFAERS: 1US FAERS
417Apparent life threatening eventFAERS: 1US FAERS
418Application site infectionFAERS: 1US FAERS
419AsthenopiaFAERS: 1US FAERS
420AsthmaFAERS: 1US FAERS
421AtelectasisFAERS: 1OFFSIDES
US FAERS
422Atrial FlutterFAERS: 1US FAERS
423Autoimmune thyroiditisFAERS: 1US FAERS
424Autonomic nervous system imbalanceFAERS: 1US FAERS
425Autonomic neuropathyFAERS: 1US FAERS
426Bed restFAERS: 1US FAERS
427BedriddenFAERS: 1OFFSIDES
US FAERS
428BelligerenceFAERS: 1US FAERS
429Benign Rolandic EpilepsyFAERS: 1US FAERS
430Blood GlucoseFAERS: 1OFFSIDES
US FAERS
431Blood alkaline phosphatase increasedFAERS: 1OFFSIDES
US FAERS
432Blood calcium abnormalFAERS: 1US FAERS
433Blood immunoglobulin A decreasedFAERS: 1US FAERS
434Blood magnesium decreasedFAERS: 1OFFSIDES
US FAERS
435Blood mercury abnormalFAERS: 1US FAERS
436Blood pH decreasedFAERS: 1US FAERS
437Blood phosphorus increasedFAERS: 1OFFSIDES
US FAERS
438Blood sodium abnormalFAERS: 1US FAERS
439Blood sodium increasedFAERS: 1OFFSIDES
US FAERS
440Blood testosterone increasedFAERS: 1US FAERS
441Breast FeedingFAERS: 1US FAERS
442Bronchial secretion retentionFAERS: 1US FAERS
443BronchospasmFAERS: 1US FAERS
444BruxismFAERS: 1US FAERS
445Cerebral PalsyFAERS: 1US FAERS
446CholecystitisFAERS: 1US FAERS
447Chronic throat clearingFAERS: 1US FAERS
448Citrobacter infectionFAERS: 1US FAERS
449ClumsinessFAERS: 1US FAERS
450Coating in mouthFAERS: 1US FAERS
451Compulsive cheek bitingFAERS: 1US FAERS
452Compulsive handwashingFAERS: 1US FAERS
453Cortisol decreasedFAERS: 1US FAERS
454Creatinine renal clearance decreasedFAERS: 1US FAERS
455Crystal urine presentFAERS: 1US FAERS
456DeafnessFAERS: 1OFFSIDES
US FAERS
457Developmental Coordination DisorderFAERS: 1US FAERS
458Device occlusionFAERS: 1US FAERS
459DiverticulumFAERS: 1OFFSIDES
US FAERS
460Dose calculation errorFAERS: 1US FAERS
461DroolingFAERS: 1US FAERS
462Drug administered at inappropriate siteFAERS: 1US FAERS
463Drug dispensed to wrong patientFAERS: 1US FAERS
464Drug level decreasedFAERS: 1US FAERS
465Drug physiologic incompatibilityFAERS: 1US FAERS
466Drug toxicityFAERS: 1US FAERS
467DysgraphiaFAERS: 1US FAERS
468Early satietyFAERS: 1US FAERS
469Economic problemFAERS: 1OFFSIDES
US FAERS
470Emergency CareFAERS: 1US FAERS
471Erythema MultiformeFAERS: 1US FAERS
472Escherichia infectionFAERS: 1US FAERS
473Expired device usedFAERS: 1US FAERS
474Exposure via inhalationFAERS: 1US FAERS
475ExsanguinationFAERS: 1US FAERS
476Eye BurnsFAERS: 1US FAERS
477Eye allergyFAERS: 1US FAERS
478Facial PainFAERS: 1US FAERS
479Failure of child resistant mechanism for pharmaceutical productFAERS: 1US FAERS
480Feeding disorder of infancy OR early childhoodFAERS: 1US FAERS
481FibromyalgiaFAERS: 1US FAERS
482FibrosisFAERS: 1US FAERS
483Fight in schoolFAERS: 1US FAERS
484Fine motor delayFAERS: 1US FAERS
485Food aversionFAERS: 1US FAERS
486FormicationFAERS: 1US FAERS
487FrustrationFAERS: 1US FAERS
488Gait inabilityFAERS: 1US FAERS
489Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
490Gastric hypomotilityFAERS: 1US FAERS
491Gastric pH decreasedFAERS: 1US FAERS
492Gastrointestinal hypermotilityFAERS: 1US FAERS
493Gastrointestinal hypomotilityFAERS: 1US FAERS
494Gastrointestinal inflammationFAERS: 1US FAERS
495Gastrointestinal viral infectionFAERS: 1US FAERS
496General symptomFAERS: 1US FAERS
497Genital burning sensationFAERS: 1US FAERS
498Genital discomfortFAERS: 1US FAERS
499Gingival HyperplasiaFAERS: 1US FAERS
500GlaucomaFAERS: 1US FAERS
501Gluten sensitivityFAERS: 1US FAERS
502Granulomatous pneumonitisFAERS: 1US FAERS
503Growing painsFAERS: 1US FAERS
504Hair injuryFAERS: 1US FAERS
505Head titubationFAERS: 1US FAERS
506Hearing disabilityFAERS: 1US FAERS
507Hepatic EncephalopathyFAERS: 1US FAERS
508HomicideFAERS: 1US FAERS
509HordeolumFAERS: 1OFFSIDES
US FAERS
510House dust allergyFAERS: 1US FAERS
511Human BiteFAERS: 1US FAERS
512HypersomniaFAERS: 1US FAERS
513HyperthyroidismFAERS: 1US FAERS
514HypokinesiaFAERS: 1US FAERS
515Hyponatraemic seizureFAERS: 1US FAERS
516Hyporesponsive to stimuliFAERS: 1US FAERS
517HypothyroidismFAERS: 1US FAERS
518HysterectomyFAERS: 1US FAERS
519Immune thrombocytopenic purpuraFAERS: 1US FAERS
520ImpetigoFAERS: 1US FAERS
521IncoherentFAERS: 1OFFSIDES
US FAERS
522Incorrect drug dosage form administeredFAERS: 1US FAERS
523Incorrect route of product administrationFAERS: 1US FAERS
524Incorrect storage of drugFAERS: 1US FAERS
525Increased tendency to bruiseFAERS: 1US FAERS
526Inhibitory drug interactionFAERS: 1US FAERS
527Initial insomniaFAERS: 1US FAERS
528Intentional device use issueFAERS: 1US FAERS
529Intercepted product dispensing errorFAERS: 1US FAERS
530Intestinal resectionFAERS: 1US FAERS
531Joint Range of Motion DecreasedFAERS: 1US FAERS
532Joint stiffnessFAERS: 1US FAERS
533LaryngitisFAERS: 1US FAERS
534Lip pruritusFAERS: 1US FAERS
535Loss of personal independence in daily activitiesFAERS: 1US FAERS
536Maternal exposure during breast feedingFAERS: 1US FAERS
537Medical device complicationFAERS: 1US FAERS
538Medical procedureFAERS: 1US FAERS
539Medication tamperingFAERS: 1US FAERS
540Mental RetardationFAERS: 1US FAERS
541Mesenteric vascular insufficiencyFAERS: 1US FAERS
542Migraine with AuraFAERS: 1US FAERS
543MiliariaFAERS: 1US FAERS
544Motion SicknessFAERS: 1US FAERS
545Multiple allergiesFAERS: 1US FAERS
546Muscle FatigueFAERS: 1US FAERS
547Muscle tightnessFAERS: 1US FAERS
548Musculoskeletal chest painFAERS: 1US FAERS
549MutismFAERS: 1OFFSIDES
US FAERS
550MyopathyFAERS: 1US FAERS
551Nasal discomfortFAERS: 1US FAERS
552Negative thoughtsFAERS: 1US FAERS
553Nephrotic SyndromeFAERS: 1US FAERS
554NeuritisFAERS: 1US FAERS
555NeutropeniaFAERS: 1US FAERS
556No adverse effectFAERS: 1US FAERS
557No reaction on previous exposure to drugFAERS: 1US FAERS
558NystagmusFAERS: 1US FAERS
559Obsessive-compulsive symptomFAERS: 1US FAERS
560Optic NeuritisFAERS: 1US FAERS
561Oral mucosal erythemaFAERS: 1US FAERS
562Oropharyngeal plaqueFAERS: 1US FAERS
563OsteoporosisFAERS: 1OFFSIDES
US FAERS
564Ovarian cancer stage IIIFAERS: 1US FAERS
565Oxygen supplementationFAERS: 1US FAERS
566PCO2 decreasedFAERS: 1US FAERS
567Pain of skinFAERS: 1US FAERS
568Palatal swellingFAERS: 1US FAERS
569Pancreatic enlargementFAERS: 1US FAERS
570Paranasal sinus hyposecretionFAERS: 1US FAERS
571Perforated ulcerFAERS: 1US FAERS
572Perianal erythemaFAERS: 1US FAERS
573Pharmaceutical product counterfeitFAERS: 1US FAERS
574Pharyngeal lesionFAERS: 1US FAERS
575Physical assaultFAERS: 1US FAERS
576Pleuritic painFAERS: 1US FAERS
577PneumoniaFAERS: 1US FAERS
578PolydipsiaFAERS: 1US FAERS
579Post procedural complicationFAERS: 1US FAERS
580Post-Traumatic Stress DisorderFAERS: 1US FAERS
581Postural Orthostatic Tachycardia SyndromeFAERS: 1US FAERS
582Precocious PubertyFAERS: 1US FAERS
583PregnancyFAERS: 1US FAERS
584Procedural complicationFAERS: 1US FAERS
585Product blister packaging issueFAERS: 1US FAERS
586Product contamination microbialFAERS: 1US FAERS
587Product gel formationFAERS: 1US FAERS
588Product measured potency issueFAERS: 1US FAERS
589Product packaging counterfeitFAERS: 1US FAERS
590Product selection errorFAERS: 1US FAERS
591Product shape issueFAERS: 1US FAERS
592Product size issueFAERS: 1US FAERS
593Productive CoughFAERS: 1OFFSIDES
US FAERS
594Prostatic painFAERS: 1US FAERS
595Purulent dischargeFAERS: 1US FAERS
596Quality of life decreasedFAERS: 1US FAERS
597RadiculitisFAERS: 1US FAERS
598RalesFAERS: 1US FAERS
599Reaction to drug excipientsFAERS: 1US FAERS
600Reaction to preservativesFAERS: 1US FAERS
601Rectal ObstructionFAERS: 1US FAERS
602Rectal ProlapseFAERS: 1US FAERS
603Rectal spasmFAERS: 1US FAERS
604RectoceleFAERS: 1US FAERS
605Refusal of treatment by relativeFAERS: 1US FAERS
606Renal cystFAERS: 1OFFSIDES
US FAERS
607Respiratory FailureFAERS: 1OFFSIDES
US FAERS
608RhinalgiaFAERS: 1US FAERS
609RosaceaFAERS: 1US FAERS
610ScabFAERS: 1US FAERS
611SepsisFAERS: 1US FAERS
612Serratia sepsisFAERS: 1US FAERS
613Sinus painFAERS: 1US FAERS
614Skin UlcerFAERS: 1US FAERS
615Skin WrinklingFAERS: 1US FAERS
616Slow speechFAERS: 1US FAERS
617StaringFAERS: 1US FAERS
618StrabismusFAERS: 1US FAERS
619StubbornnessFAERS: 1US FAERS
620Suicide threatFAERS: 1US FAERS
621Supraventricular tachycardiaFAERS: 1US FAERS
622Suspected counterfeit productFAERS: 1US FAERS
623Suture related complicationFAERS: 1US FAERS
624TachycardiaFAERS: 1US FAERS
625TalipesFAERS: 1US FAERS
626Tardive DyskinesiaFAERS: 1US FAERS
627Tension HeadacheFAERS: 1US FAERS
628Terminal stateFAERS: 1US FAERS
629Therapeutic product effect decreasedFAERS: 1US FAERS
630Therapeutic product effect variableFAERS: 1US FAERS
631Throat clearingFAERS: 1US FAERS
632ThrombosisFAERS: 1US FAERS
633Tongue blisteringFAERS: 1US FAERS
634Tongue erythemaFAERS: 1US FAERS
635Tooth LossFAERS: 1US FAERS
636TrichotillomaniaFAERS: 1US FAERS
637Upper respiratory tract congestionFAERS: 1US FAERS
638Upper-airway cough syndromeFAERS: 1US FAERS
639Urethritis noninfectiveFAERS: 1US FAERS
640Urine flow decreasedFAERS: 1US FAERS
641Urine oxalate increasedFAERS: 1US FAERS
642Vascular ruptureFAERS: 1US FAERS
643Violence-related symptomFAERS: 1US FAERS
644Visceral PainFAERS: 1US FAERS
645Vulvovaginal burning sensationFAERS: 1US FAERS
646Vulvovaginal discomfortFAERS: 1US FAERS
647Waist circumference increasedFAERS: 1US FAERS
648Walking aid userFAERS: 1US FAERS
649Weight below normalFAERS: 1US FAERS
650Wheelchair userFAERS: 1US FAERS
651White blood cell count decreasedFAERS: 1US FAERS
652Wrong patient received productFAERS: 1US FAERS
653jaundiceFAERS: 1US FAERS
654skin abrasionFAERS: 1US FAERS
655Abnormal cervical smearOFFSIDES
656Abnormal visionOFFSIDES
657Actinic keratosisOFFSIDES
658Acute bronchitisOFFSIDES
659Acute graft versus host disease in liverOFFSIDES
660Acute respiratory failureOFFSIDES
661AmphetaminesOFFSIDES
662AnalgesiaOFFSIDES
663Aneuploidy30763314CTD
664AnhedoniaOFFSIDES
665Anticonvulsant drug level decreasedOFFSIDES
666Anticonvulsant toxicityOFFSIDES
667ApneaOFFSIDES
668Arachnoiditis3291836CTD
669ArteriosclerosisOFFSIDES
670Arteriovenous fistula thrombosisOFFSIDES
671Atrial tachycardiaOFFSIDES
672BereavementOFFSIDES
673BlepharitisOFFSIDES
674Blood chloride decreasedOFFSIDES
675Blood phosphorus decreasedOFFSIDES
676Blood sodiumOFFSIDES
677Blurred visionOFFSIDES
678Bone Diseases, Developmental20952502CTD
679BradycardiaOFFSIDES
680Brain AbscessOFFSIDES
681Bronchoalveolar LavageOFFSIDES
682Capillary Leak SyndromeOFFSIDES
683Cardiac DeathOFFSIDES
684Cardiomyopathies6538499CTD
685CellulitisOFFSIDES
686Central venous catheter removalOFFSIDES
687Chemical and Drug Induced Liver Injury6499799
23831209
CTD
688Chronic respiratory failureOFFSIDES
689Colonic Neoplasms10866305CTD
690Colonic StenosisOFFSIDES
691Completed SuicideCanada Vigilance: 1Canada Vigilance
692Compression fractureOFFSIDES
693ConfabulationOFFSIDES
694Cytolytic hepatitisOFFSIDES
695Cytomegalovirus hepatitisOFFSIDES
696DemyelinationOFFSIDES
697Dental abscessOFFSIDES
698Denture wearerOFFSIDES
699Device related infectionOFFSIDES
700DiabetesOFFSIDES
701Diabetes InsipidusOFFSIDES
702Diabetes mellitus inadequate controlOFFSIDES
703Diabetic NephropathyOFFSIDES
704DiarrheaOFFSIDES
705Diastolic dysfunctionOFFSIDES
706Diet refusalOFFSIDES
707DuodenitisOFFSIDES
708Ejection Fraction DecreasedOFFSIDES
709Embolic strokeOFFSIDES
710Endodontic procedureOFFSIDES
711Endometrial HyperplasiaOFFSIDES
712Engraftment syndromeOFFSIDES
713Enterococcal infectionOFFSIDES
714Erectile dysfunctionOFFSIDES
715Face LiftOFFSIDES
716Febrile bone marrow aplasiaOFFSIDES
717Fluid imbalanceOFFSIDES
718Food AllergyOFFSIDES
719Gait Disorders, Neurologic20952502CTD
720Genital painOFFSIDES
721GranulocytosisOFFSIDES
722Haptoglobin DecreasedOFFSIDES
723Hepatitis B antibody positiveOFFSIDES
724Hospice CareOFFSIDES
725HypercapniaOFFSIDES
726HyperkeratosisOFFSIDES
727Hyperoxaluria

View details

CTD
728Hypertensive heart diseaseOFFSIDES
729HypogeusiaCanada Vigilance: 1Canada Vigilance
730HypoxiaOFFSIDES
731Intervertebral Disc DegenerationOFFSIDES
732Kidney Calculi24145091CTD
733Left Ventricular HypertrophyOFFSIDES
734Left atrial dilatationOFFSIDES
735LeukoencephalopathyOFFSIDES
736Leukopenia neonatalOFFSIDES
737LipaseOFFSIDES
738Liver transplant rejectionOFFSIDES
739Loose toothOFFSIDES
740Mallory-Weiss SyndromeOFFSIDES
741Mastication disorderOFFSIDES
742Medical device removalOFFSIDES
743Multiple sclerosis relapseOFFSIDES
744Muscle WeaknessOFFSIDES
745Necrosis23831209CTD
746NegativismOFFSIDES
747Nerve BlockOFFSIDES
748Nervous tensionOFFSIDES
749Neutropenic infectionOFFSIDES
750NoduleOFFSIDES
751Non-cardiac chest painOFFSIDES
752Oral Cavity FistulaOFFSIDES
753OrthopneaOFFSIDES
754OsteomyelitisOFFSIDES
755OsteoradionecrosisOFFSIDES
756Paranasal sinus hypersecretionOFFSIDES
757ParaplegiaOFFSIDES
758Peritoneal DialysisOFFSIDES
759PhlebitisOFFSIDES
760Physical disabilityOFFSIDES
761Poisoning1621360CTD
762Post lumbar puncture syndromeOFFSIDES
763Posterior capsule opacificationOFFSIDES
764Prealbumin decreasedOFFSIDES
765Precancerous Conditions10866305CTD
766Prenatal Injuries20952502CTD
767Protein total increasedOFFSIDES
768PseudocystOFFSIDES
769Pulmonary congestionOFFSIDES
770Restrictive cardiomyopathyOFFSIDES
771RhinorrheaOFFSIDES
772Secondary sequestrumOFFSIDES
773Sleep disorder due to general medical condition, insomnia typeCanada Vigilance: 1Canada Vigilance
774Sputum culture positiveOFFSIDES
775Stevens-Johnson SyndromeOFFSIDES
776Teratogenesis8650594CTD
777ThrombophlebitisOFFSIDES
778Toe operationOFFSIDES
779Tongue eruptionCanada Vigilance: 1Canada Vigilance
780Tooth ExtractionOFFSIDES
781Tooth InfectionOFFSIDES
782Unresponsive to stimuliOFFSIDES
783Upper airway obstructionOFFSIDES
784Urolithiasis9471053CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.